——Pioneering Microbial Fermentation Process Redefines Sustainable ManufacturingA prominent biotechnology enterprise in Northern China has achieved groundbreaking progress in green biosynthesis of Coenzyme Q10 (CoQ10), leveraging proprietary high-yield microbial strains and intelligent process optimi
READ MORE——Dual-Enzyme Process Redefines Sustainable Pharmaceutical Manufacturing A leading biotechnology enterprise in Northwest China has commenced commercial production of Ursodeoxycholic Acid (UDCA) active pharmaceutical ingredient (API), marking the region's inaugural transition from bulk intermediates
READ MORE——International Quality System Earns Renewed Global RecognitionRecently, a leading API manufacturer in Southwest China successfully underwent a 5-day GMP audit conducted by the European Medicines Agency (EMA). The inspection covered critical active pharmaceutical ingredients including Ampicillin Sod
READ MORE